ECONSALUT

Testing Treatments Els Tractaments, a prova If you are interested in critical thinking about treatment claims, then now it is the time to...

The Patient as Agent of Health and Health Care. Autonomy in Patient-Centered Care for Chronic Conditions Currently the concept of health...

The Value of Diagnostic Testing in Personalized Medicine Before Jevons , economists were unable to think on marginal terms. If price sho...

Ethics, priorities and cancer This is one of the most challenging questions nowadays. Anthony Culyer sheds light n this difficult issue in...

Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems inNorth America, Europ...

Excellent speech by Salvador Macip at Grifols Foundation conference on CRISPR (in catalan):

Nudges that fail Cass Sunstein shows in his las published article that nudging may fail, and explains the reasons and what to do. Great, I...

The Limitations of QALY: A Literature Review After 50 years, valuing health using QALYs is still a daunting task. Basically the debate ove...

Are You What You Eat? Healthy Behaviour and Risk Preferences I am not strictly a fan of economic experiments. They are useful, but usually...

The effect of prices on nutrition: Comparing the impact of product-and nutrient-specific taxes Nowadays, many people is asking about evide...

Medical Practice Variations The title of this post is not original, it is really from a book published in 1990 , 27 years ago! And Wennber...

Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-...

L’expérience américaine des Accountable Care Organizations:des enseignements pour la France ? After all the efforts, ACOs coverage in US i...

Methods in comparative effectiveness research If comparative effectiveness is the new fram for valuing health technologies, then we need t...